4//SEC Filing
Martin Michael Robert 4
Accession 0001628280-22-029215
CIK 0001600620other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:05 PM ET
Size
4.9 KB
Accession
0001628280-22-029215
Insider Transaction Report
Form 4
Martin Michael Robert
Chief Business Officer
Transactions
- Purchase
Common Stock
2022-11-07$5.16/sh+30,000$154,800→ 89,512 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.98 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001837647
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:05 PM ET
- Size
- 4.9 KB